The stock has a 36-month beta value of -1.05. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ICU is 8.50M, and at present, short sellers hold a 3.94% of that float. On March 27, 2025, the average trading volume of ICU was 396.63K shares.
ICU) stock’s latest price update
SeaStar Medical Holding Corp (NASDAQ: ICU)’s stock price has soared by 9.95 in relation to previous closing price of 2.21. Nevertheless, the company has seen a gain of 15.71% in its stock price over the last five trading days. globenewswire.com reported 2025-03-24 that DENVER, March 24, 2025 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its fourth quarter and year-end 2024 financial results after market close on Thursday, March 27, 2025, and host a webcast and conference call to discuss its financial results and business progress.
ICU’s Market Performance
SeaStar Medical Holding Corp (ICU) has seen a 15.71% rise in stock performance for the week, with a 52.83% gain in the past month and a 17.96% surge in the past quarter. The volatility ratio for the week is 8.81%, and the volatility levels for the past 30 days are at 9.81% for ICU. The simple moving average for the past 20 days is 23.80% for ICU’s stock, with a -39.27% simple moving average for the past 200 days.
ICU Trading at 30.44% from the 50-Day Moving Average
After a stumble in the market that brought ICU to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -88.26% of loss for the given period.
Volatility was left at 9.81%, however, over the last 30 days, the volatility rate increased by 8.81%, as shares surge +52.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +24.62% upper at present.
During the last 5 trading sessions, ICU rose by +15.71%, which changed the moving average for the period of 200-days by -54.69% in comparison to the 20-day moving average, which settled at $1.96. In addition, SeaStar Medical Holding Corp saw 25.26% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ICU starting from Neuman John, who purchase 10,000 shares at the price of $5.24 back on Aug 15 ’24. After this action, Neuman John now owns 30,000 shares of SeaStar Medical Holding Corp, valued at $52,396 using the latest closing price.
Neuman John, the Director of SeaStar Medical Holding Corp, purchase 10,000 shares at $4.35 during a trade that took place back on Jun 17 ’24, which means that Neuman John is holding 20,000 shares at $43,521 based on the most recent closing price.
Stock Fundamentals for ICU
Current profitability levels for the company are sitting at:
- -235.56 for the present operating margin
- 1.0 for the gross margin
The net margin for SeaStar Medical Holding Corp stands at -445.38. The total capital return value is set at 7.81.
Currently, EBITDA for the company is -11.14 million with net debt to EBITDA at 0.07. When we switch over and look at the enterprise to sales, we see a ratio of 280.93. The receivables turnover for the company is 1.0for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.54.
Conclusion
To sum up, SeaStar Medical Holding Corp (ICU) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
